These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2560675)

  • 1. The effect of sulfonylurea therapy on defective calcium movement associated with diabetic cardiomyopathy.
    Mozaffari MS; Allo S; Schaffer SW
    Can J Physiol Pharmacol; 1989 Nov; 67(11):1431-6. PubMed ID: 2560675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased sarcolemmal Ca2+ transport activity in skeletal muscle of diabetic rats.
    Taira Y; Hata T; Ganguly PK; Elimban V; Dhalla NS
    Am J Physiol; 1991 Apr; 260(4 Pt 1):E626-32. PubMed ID: 1850203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms that may be involved in calcium tolerance of the diabetic heart.
    Ziegelhöffer A; Ravingerová T; Styk J; Seboková J; Waczulíková I; Breier A; Dzurba A; Volkovová K; Cársky J; Turecký L
    Mol Cell Biochem; 1997 Nov; 176(1-2):191-8. PubMed ID: 9406161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic sulfonylurea treatment on the myocardium of insulin-dependent diabetic rats.
    Mozaffari MS; Wilson GL; Schaffer SW
    Can J Physiol Pharmacol; 1988 Dec; 66(12):1481-6. PubMed ID: 3147810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in cardiac sarcolemmal Ca2+ pump activity during diabetes mellitus.
    Heyliger CE; Prakash A; McNeill JH
    Am J Physiol; 1987 Mar; 252(3 Pt 2):H540-4. PubMed ID: 3030140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetic cardiomyopathy in rats: biochemical mechanisms of increased tolerance to calcium overload.
    Ziegelhöffer A; Ravingerová T; Styk J; Tribulová N; Volkovová K; Seboková J; Breier A
    Diabetes Res Clin Pract; 1996 Jul; 31 Suppl():S93-103. PubMed ID: 8864647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcolemmal Ca2+ transport activities in cardiac hypertrophy caused by pressure overload.
    Nakanishi H; Makino N; Hata T; Matsui H; Yano K; Yanaga T
    Am J Physiol; 1989 Aug; 257(2 Pt 2):H349-56. PubMed ID: 2548404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of kaempferol, a flavonoid compound, on membrane-bound ATPases in streptozotocin-induced diabetic rats.
    Al-Numair KS; Veeramani C; Alsaif MA; Chandramohan G
    Pharm Biol; 2015; 53(9):1372-8. PubMed ID: 25853957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac sarcolemmal Na(+)-Ca2+ exchange and Na(+)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats.
    Golfman L; Dixon IM; Takeda N; Lukas A; Dakshinamurti K; Dhalla NS
    Mol Cell Biochem; 1998 Nov; 188(1-2):91-101. PubMed ID: 9823015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart sarcolemmal ATPase and calcium binding activities in rats fed a high cholesterol diet.
    Moffat MP; Dhalla NS
    Can J Cardiol; 1985; 1(3):194-200. PubMed ID: 2996727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcolemmal Ca2+ transport in streptozotocin-induced diabetic cardiomyopathy in rats.
    Makino N; Dhalla KS; Elimban V; Dhalla NS
    Am J Physiol; 1987 Aug; 253(2 Pt 1):E202-7. PubMed ID: 2956889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcolemmal Na+-K+-ATPase activity in diabetic rat heart.
    Pierce GN; Dhalla NS
    Am J Physiol; 1983 Sep; 245(3):C241-7. PubMed ID: 6137147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of heart function and Na+-K+-ATPase activity by etomoxir in diabetic rats.
    Kato K; Chapman DC; Rupp H; Lukas A; Dhalla NS
    J Appl Physiol (1985); 1999 Mar; 86(3):812-8. PubMed ID: 10066690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Modulation of the activity of (Na+ + K+)-ATPase, Mg2+-APase and Ca2+-ATPase with low calcium affinity in myocardial sarcolemma using ribose-5-phosphate].
    Monosíková R; Ziegelhöffer A; Breier A; Dzurba A; Vrbjar N
    Bratisl Lek Listy; 1987 Jul; 88(1):28-33. PubMed ID: 2822208
    [No Abstract]   [Full Text] [Related]  

  • 15. Sarcolemmal Ca2+-binding and enzyme activities in myocardium from hypothyroid rat.
    Daly MJ; Dzurba A; Tuana BS; Dhalla NS
    Can J Cardiol; 1986; 2(6):356-61. PubMed ID: 3026594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-insulin-dependent diabetes-induced defects in cardiac cellular calcium regulation.
    Allo SN; Lincoln TM; Wilson GL; Green FJ; Watanabe AM; Schaffer SW
    Am J Physiol; 1991 Jun; 260(6 Pt 1):C1165-71. PubMed ID: 1829324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac sarcolemma as a possible site of action of caffeine in rat heart.
    Gupta MP; Makino N; Takeo S; Kaneko M; Dhalla NS
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1188-94. PubMed ID: 2175796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart mitochondrial function in chronic experimental diabetes in rats.
    Pierce GN; Dhalla NS
    Can J Cardiol; 1985 Jan; 1(1):48-54. PubMed ID: 2996724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersensitivity to calcium associated with an increased sarcolemmal Ca2+-ATPase activity in diabetic rat heart.
    Borda E; Pascual J; Wald M; Sterin-Borda L
    Can J Cardiol; 1988 Mar; 4(2):97-101. PubMed ID: 2452676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of calcium antagonists on heart sarcolemmal (Na+ + K(+)-ATPase.
    Dzurba A; Breier A; Slezák J; Stankovicová T; Vrbjar N; Ziegelhöffer A
    Bratisl Lek Listy; 1991; 92(3-4):155-8. PubMed ID: 1851463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.